MX2020009556A - Metodo para producir molecula de acido ribonucleico (arn) de hebra unica en horquilla. - Google Patents

Metodo para producir molecula de acido ribonucleico (arn) de hebra unica en horquilla.

Info

Publication number
MX2020009556A
MX2020009556A MX2020009556A MX2020009556A MX2020009556A MX 2020009556 A MX2020009556 A MX 2020009556A MX 2020009556 A MX2020009556 A MX 2020009556A MX 2020009556 A MX2020009556 A MX 2020009556A MX 2020009556 A MX2020009556 A MX 2020009556A
Authority
MX
Mexico
Prior art keywords
stranded
molecule
stranded oligorna
rna molecule
stranded rna
Prior art date
Application number
MX2020009556A
Other languages
English (en)
Inventor
Katsuhiko Iseki
Keiichi Okimura
Hideaki Inada
Masato Sanosaka
Ayumi TAKASHINA
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of MX2020009556A publication Critical patent/MX2020009556A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y605/00—Ligases forming phosphoric ester bonds (6.5)
    • C12Y605/01—Ligases forming phosphoric ester bonds (6.5) forming phosphoric ester bonds (6.5.1)
    • C12Y605/01003—RNA ligase (ATP) (6.5.1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/122—Hairpin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un método para producir una molécula de ARN de hebra única en horquilla capaz de inhibir la expresión de un gen objetivo, el método comprende: (i) una etapa de hibridación para hibridar una primera molécula de oligoARN de hebra única y una segunda molécula de oligoARN de hebra única; y (ii) una etapa de ligación para ligar el extremo 3´ de la primera molécula de oligoARN de hebra única y el extremo 5´ de la segunda molécula de oligoARN de hebra única por una ligasa de la familia Rnl2, en donde una secuencia producida por ligación de la primera molécula de oligoARN de hebra única y la segunda molécula de oligoARN de hebra única comprende una secuencia que inhibe la expresión del gen el gen objetivo.
MX2020009556A 2018-03-30 2019-03-29 Metodo para producir molecula de acido ribonucleico (arn) de hebra unica en horquilla. MX2020009556A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018070423 2018-03-30
PCT/JP2019/013923 WO2019189722A1 (ja) 2018-03-30 2019-03-29 ヘアピン型一本鎖ｒｎａ分子の製造方法

Publications (1)

Publication Number Publication Date
MX2020009556A true MX2020009556A (es) 2020-10-05

Family

ID=68061953

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020009556A MX2020009556A (es) 2018-03-30 2019-03-29 Metodo para producir molecula de acido ribonucleico (arn) de hebra unica en horquilla.

Country Status (15)

Country Link
US (2) US11920131B2 (es)
EP (1) EP3778886A4 (es)
JP (2) JP6631751B1 (es)
KR (1) KR20200136363A (es)
CN (1) CN111819280A (es)
AU (1) AU2019242331A1 (es)
BR (1) BR112020017769A2 (es)
CA (1) CA3094160A1 (es)
IL (1) IL277346A (es)
MX (1) MX2020009556A (es)
PH (1) PH12020551487A1 (es)
RU (1) RU2020130258A (es)
TW (1) TWI772632B (es)
WO (1) WO2019189722A1 (es)
ZA (1) ZA202005149B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11891602B2 (en) 2018-10-02 2024-02-06 Toray Industries, Inc. Method of producing hairpin single-stranded RNA molecules
KR20220123398A (ko) * 2019-12-03 2022-09-06 빔 테라퓨틱스, 인크. 합성 가이드 rna, 이의 조성물, 방법 및 용도
EP4130018A4 (en) * 2020-03-27 2024-04-17 Sumitomo Chemical Company, Limited PROCESS FOR THE PRODUCTION OF NUCLEIC ACID OLIGOMERS
EP4392560A1 (en) * 2021-08-27 2024-07-03 Peking University Constructs and methods for preparing circular rna
CN117660374A (zh) * 2022-09-08 2024-03-08 凯莱英医药集团（天津）股份有限公司 Rna连接酶在寡核苷酸制备上的应用
CN115774075B (zh) * 2023-02-15 2023-06-06 江苏耀海生物制药有限公司 一种基于RP-HPLC分析体外转录产物成分circRNA的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003532380A (ja) * 1999-12-02 2003-11-05 モレキュラー ステージング，インコーポレイテッド 線状自己アニーリングセグメントからの一本鎖環状ｄｎａの産出
AU2003256857A1 (en) * 2002-08-08 2004-02-25 Dharmacon, Inc. Short interfering rnas having a hairpin structure containing a non-nucleotide loop
JP5296328B2 (ja) 2007-05-09 2013-09-25 独立行政法人理化学研究所 １本鎖環状ｒｎａおよびその製造方法
US20110055965A1 (en) 2008-02-15 2011-03-03 Hiroshi Abe Cycle single-stranded nucleic acid complex and method for producing the same
WO2011052013A1 (ja) * 2009-10-29 2011-05-05 株式会社バイオダイナミクス研究所 核酸鎖の結合および修飾方法
WO2012005368A1 (ja) 2010-07-08 2012-01-12 株式会社ボナック 遺伝子発現制御のための一本鎖核酸分子
EP2639307B1 (en) 2010-08-03 2015-03-04 Bonac Corporation Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
CN103906758B (zh) 2011-08-25 2017-05-10 株式会社博纳克 配糖体化合物、硫醚的制造方法、醚、醚的制造方法、配糖体化合物的制造方法及核酸的制造方法
WO2013077446A1 (ja) * 2011-11-26 2013-05-30 株式会社ボナック 遺伝子発現制御のための一本鎖核酸分子
CN104039961A (zh) 2012-01-07 2014-09-10 株式会社博纳克 具有氨基酸骨架的单链核酸分子
WO2014110272A1 (en) 2013-01-09 2014-07-17 The Penn State Research Foundation Low sequence bias single-stranded dna ligation
US10377788B2 (en) 2015-04-02 2019-08-13 Bonac Corporation Method for producing glycoside compounds
WO2017035090A1 (en) 2015-08-21 2017-03-02 Thomas Jefferson University Dumbbell-pcr: a method to quantify specific small rna variants with a single nucleotide resolution at terminal sequences
SG11201803410RA (en) 2015-10-30 2018-05-30 Bonac Corp COMPOSITION STABLY CONTAINING SINGLE-STRANDED NUCLEIC ACID MOLECULE THAT SUPPRESSES EXPRESSION OF TGF-ß1 GENE
GB201612011D0 (en) 2016-07-11 2016-08-24 Glaxosmithkline Ip Dev Ltd Novel processes for the production of oligonucleotides
JP6815601B2 (ja) 2016-11-01 2021-01-20 スタンレー電気株式会社 ウルツ鉱構造のＺｎＯＳ混晶粒子の製造方法
JPWO2018182008A1 (ja) 2017-03-31 2020-02-06 株式会社ボナック 遺伝子発現制御機能を有する環状型核酸分子
TWI830718B (zh) * 2018-02-09 2024-02-01 日商住友化學股份有限公司 核酸分子之製造方法
US20210115485A1 (en) 2018-03-30 2021-04-22 Sumitomo Chemical Company, Limited Method for producing single-strand rna

Also Published As

Publication number Publication date
EP3778886A4 (en) 2022-11-02
EP3778886A1 (en) 2021-02-17
CA3094160A1 (en) 2019-10-03
JP6631751B1 (ja) 2020-01-15
PH12020551487A1 (en) 2021-08-23
TW202003842A (zh) 2020-01-16
JP7363316B2 (ja) 2023-10-18
US11920131B2 (en) 2024-03-05
JPWO2019189722A1 (ja) 2020-04-30
WO2019189722A1 (ja) 2019-10-03
BR112020017769A2 (pt) 2021-01-05
JP2019213567A (ja) 2019-12-19
US20240167033A1 (en) 2024-05-23
RU2020130258A (ru) 2022-05-04
TWI772632B (zh) 2022-08-01
ZA202005149B (en) 2022-01-26
IL277346A (en) 2020-10-29
US20210024930A1 (en) 2021-01-28
AU2019242331A1 (en) 2020-09-10
CN111819280A (zh) 2020-10-23
KR20200136363A (ko) 2020-12-07

Similar Documents

Publication Publication Date Title
PH12020551487A1 (en) Method for producing hairpin single-stranded rna molecule
EA201991369A1 (ru) Модифицированные направляющие рнк
CY1124845T1 (el) Μεθοδοι παροχης μονοκλωνου rna
MX2019014264A (es) Un metodo de amplificacion de transcriptoma unicelular.
MY194798A (en) Novel adenylosuccinate synthetase and method for producing purine nucleotides using the same
MX2019006082A (es) Dinucleótidos cíclicos como agonistas de sting.
PH12019502294A1 (en) Novel bispecific antigen binding molecules capable of specific binding to cd40 and to fap
MX2020009366A (es) Anticuerpos anti-cd73 y usos de los mismos.
CO2020015314A2 (es) Composiciones de arni contra el angiotensinógeno (agt) y métodos para su uso
BR122021025194A8 (pt) Molécula de ácido nucleico, método para obter rna, rna, método para obter um peptídeo ou proteína e usos in vitro ou ex vivo do rna
CR20140538A (es) Métodos y composiciones para la modificación de adn objetivo dirigida por arn y para la modificación de la transcripción dirigida por arn
MX2021006745A (es) Constructos de iarn modificados quimicamente y usos de estos.
MX2021007001A (es) Moleculas inhibidoras de acido nucleico de cadena doble que contienen un tribucle.
EP3778901A4 (en) NEW PROMOTER AND PROCESS FOR THE PRODUCTION OF L-AMINO ACID USING THE PROMOTER
AR113458A1 (es) Método para regular la expresión génica
MX2020010802A (es) Moleculas inhibidoras de acidos nucleicos de caracter bicatenario modificadas con nucleotidos que aumentan la tm.
MX2021004454A (es) Anticuerpos anti-sinucleina.
CO2021012310A2 (es) Composiciones y métodos para tratar laminopatías
MX2021013913A (es) Composiciones y metodos para el tratamiento de enfermedades mediadas por atpasa.
CL2021002842A1 (es) Moléculas inhibidoras de ácido nucleico bicatenario con cadenas de sentido acortadas
EP3950881A4 (en) LIGHT-EMITTING ELEMENT AND METHOD FOR PRODUCTION THEREOF, AND COMPOSITION FOR A LIGHT-EMITTING ELEMENT AND METHOD FOR PRODUCTION THEREOF
EP3862431A4 (en) METHOD FOR PRODUCTION OF HAIRPIN SINGLE-STRANDED RNA MOLECULES
AR083445A1 (es) siARN CONTRA LA FIBROSIS
MX2019007110A (es) Reactivos para el tratamiento de la distrofia muscular oculofaringea (opmd) y uso de estos.
MX2021013698A (es) Composiciones y metodos para el tratamiento de la infeccion por virus de la hepatitis b (vhb).